B. Pf, Rapid diagnostic test for tuberculosis. Progress but not gold standard, Am J Respir Crit Care Med, vol.155, pp.1497-1498, 1997.

B. , D. Sw, H. Md, and O. J. Breeden-a, Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections, JAMA, vol.268, pp.1280-1286, 1992.

B. B. , C. J. Barnes-gl, C. Ko-c, and . Re, Evaluation of a wholeblood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations, Clin Infect Dis, vol.34, pp.1449-1456, 2002.

B. Js and W. Gl, Reliability of Mycobacteria Growth Indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin, J Clin Microbiol, vol.35, pp.3325-3327, 1997.

B. S. , D. P. , V. V. , G. Mc, and C. E. , Use of spoligotyping in molecular epidemiology of tuberculosis, Clin Infect Dis, vol.28, pp.939-940, 1999.

B. Gh, Serological diagnosis of tuberculosis, Eur Respir J, vol.8, pp.676-688, 1995.

B. E. , C. E. , M. , and L. S. Vallee-e, A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study, AIDS, vol.7, pp.1453-1460, 1993.

B. I. , M. Me, and K. Andersen-p, Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10, Int J Tuberc Lung Dis, vol.5, pp.462-467, 2001.

B. J. Daneshvar-m, F. Dm, and G. Rc, Selective procedures for detecting femtomole quantities of tuberculostearic acid in serum and cerebrospinal fluid by frequency-pulsed electron capture gas-liquid chromatography, J Clin Microbiol, vol.35, pp.1201-1206, 1987.

C. A. and D. Bl, Rapid diagnostic test for tuberculosis. What is the appropriate use ?, Am J Respir Crit Care Med, vol.155, pp.1804-1814, 1997.

C. Md, E. Kd, T. G. , S. M. , and M. G. , Stability of DNA fingerprints pattern produced with IS6110 in strains of Mycobacterium tuberculosis, J Clin Microbiol, vol.32, pp.262-266, 1994.

C. Of and . Control, Transmission of multiple-drug-resistant tuberculosis among immunocompromised persons in a correctional system, MMWR Morb Mortal Wkly Rep, vol.41, pp.507-509, 1991.

C. S. , R. Z. , D. Tm, G. Dj, and M. Da, Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay aith glycolipid antigens, Am Rev Respir Dis, vol.142, pp.385-390, 1990.

C. S. , R. V. , R. T. , and R. H. Horn-c, APA) antigen capture and antibody detection assays for the diagnosis of tuberculosis, Int J Tuberc Lung Dis, vol.45, issue.4, pp.47-377, 2000.

C. Dp, Y. Dm, S. Ca, N. Ps, and M. Jj, Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens, Am J Respir Crit Care Med, vol.151, pp.1872-1877, 1995.

C. Je, S. Rm, S. Tm, and P. Bb, Large-scale use of polymerase chain reaction for detection of mycobacterium tuberculosis in a routine mycobacteriology laboratory, J Clin Microbiol, vol.31, pp.2049-2056, 1993.

C. Rc, M. Gp, G. S. , and C. J. , Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampicin resistant Mycobacterium tuberculosis from New York City, J Clin Microbiol, vol.35, pp.1281-1283, 1997.

?. Tuberculose, D. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, S. Pr, . Jf, . Van-zyl et al., Intensive short course chemotherapy in the management of tuberculous meningitis, Int J Tuberc Lung Dis, vol.9, pp.704-711, 1998.

D. C. , G. Gp, W. Sleeman-k, and . Bg, Prospects for worldwide tuberculosis control under the WHO DOTS strategy, Lancet, vol.352, pp.1886-1891, 1998.

D. C. , W. Cj, B. Dm, and W. Bg, What is the limit to case detection under the DOTS strategy for tuberculosis control ? Tuberculosis (Edinb), pp.35-43, 2003.

E. Da, Strategies for the fight against tuberculosis, Pneumology, vol.48, pp.140-143, 1994.

E. Da and A. , Principes et organisation de la lutte antituberculeuse, Rev Prat, vol.46, pp.1368-1373, 1996.

E. Da, R. Hl, A. T. , T. A. Espinal-m, L. A. Simonsen-l et al., Prise en charge de la tuberculose Guide pour les pays à faibles revenus. 5 e édition Union internationale contre la tuberculose et les maladies respiratoires Global trends in resistance to antituberculosis drugs, N Engl J Med, vol.344, pp.1294-1303, 2000.

F. Tr, S. T. , P. , K. Jo, and C. Gm, The emergence of drug-resistant tuberculosis in New York City, N Engl J Med, vol.328, pp.521-526, 1993.

F. Tr, F. Pi, W. Rm, and H. Ma, Tuberculosis in New York City--turning the tide, N Engl J Med, vol.333, pp.229-233, 1995.

F. Tr and D. Cr, Tuberculosis control : past 10 years and future progress, Tuberculosis, vol.83, pp.82-85, 2003.

F. Pi, F. Larkin-c, and A. H. , Directly observed therapy in New York City. History, implementation, results, and challenges Can we control tuberculosis in high HIV prevalence settings ? Tuberculosis (Edinb), Clin Chest Med, vol.18, issue.83, pp.135-148, 1997.

G. Rd, U. Lo, S. Ne, B. E. , and K. G. , The batericidal activity of moxifloxacin in patients with pulmonary tuberculosis, Am J Respir Crit Care Med, vol.168, pp.1342-1345, 2003.

H. Ad, G. F. Hargreaves-nj, K. Jh, and S. Fm, High death rates in health care workers and teachers in Malawi, Traitements de la tuberculose et évaluation des stratégies de contrôle 91 ANALYSE, pp.34-37, 2002.

I. De, . Sanitaire, R. Gb, S. T. Mc, D. Pd et al., Les cas de tuberculose déclarés en France en http ://www.invs.sante Tuberculosis management in Europe. Task Force of the, Département des maladies infectieursesERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region, pp.233-237, 1999.

M. Cjl, S. K. , and R. A. , Tuberculosis in developing countries : burden, intervention and cost, Bull Int Union Tuberc Lung Dis, vol.65, pp.6-24, 1990.

M. Cj, D. E. , C. Hj, N. Ds, S. A. et al., Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries, Lancet, vol.338, pp.1305-1308, 1991.

M. Cjl and S. J. Oms, Expanding the WHO tuberculosis control strategy : rethinking the role of active case-finding Guide pour la surveillance de la résistance bactérienne aux médicaments antituberculeux, Int J Tuberc Lung Dis, vol.2, pp.9-15, 1997.

R. Netherlands and . Association, Revised international definitions in tuberculosis control, Int J Tuberc Lung Dis, vol.5, pp.213-215, 2001.

P. , R. Mc, L. A. Binkin-n, and R. Hl, World Health Organization Global surveillance for antituberculosis-drug resistance, N Engl J Med, vol.316, issue.338, pp.1641-1649, 1994.

R. Mc and P. A. , Evolution of WHO policies for tuberculosis control, Lancet, vol.359, pp.775-780, 1948.

R. Lb, The U-shaped curve of concern, Am Rev Respir Dis, vol.144, pp.741-742, 1991.

R. Hl, R. Watson-jm, F. M. Mc, and M. Gb, Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases, Eur Respir J, vol.9, pp.1097-1104, 1996.

?. Tuberculose, B. F. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, and L. E. , Mésusage et/ou surdosage de vaccin BCG : suivi et bilan de 4 ans de notification spontanée, pp.739-742, 2001.

K. R. Bhandari-b and M. Sl, Management of post-BCG lymphadenitis, The Indian Journal of Pediatrics, vol.32, issue.5, pp.367-370, 1980.
DOI : 10.1007/BF02759827

C. Jl, Infection disséminée idiopathique par le BCG ou les mycobactéries atypiques, Arch Pediatr, vol.4, pp.883-885, 1997.

C. Jl, J. E. , L. S. , B. S. , and F. A. , Immunological conditions of children with BCG disseminated infection, Lancet, vol.346, p.581, 1995.

C. Jl, B. S. , E. J. , J. E. , and L. S. , Idiopathic disseminated bacillus Calmette-Guérin infection : a french national retrospective study, Pediatrics, vol.98, pp.774-778, 1996.

D. R. , J. E. , D. S. , F. Mc, and S. Jl, Partial interferon gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection, J Infect Dis, vol.181, pp.379-384, 2000.

H. Sp, G. J. , and M. Jt, Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination, Brit Med J, vol.290, p.970, 1985.

H. T. , W. B. Vaillant-jn, A. L. , and P. J. , A survey of physician vaccine risk perception and immunization practices for subjects with immunological diseases, Vaccine, vol.19, pp.908-915, 2001.

?. Tuberculose, J. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie-158, C. Pm, T. J. Mk, and C. Hm, Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organ, vol.79, pp.337-343, 2001.

J. E. , A. F. , L. S. , R. P. , and E. Jf, Interferon-gammareceptor deficiency in an infant with fatal bacille Calmette-Guerin infection, N Engl J Med, vol.335, pp.1956-1961, 1996.

K. Sk, J. Y. , and S. Mv, BCG associated adenitis, Lancet, vol.341, p.970, 1993.

K. L. Brander-e, K. M. , W. , and B. A. , Osteitis after newborn vaccination with three different Bacillus Calmette-Guerin vaccines : twenty nine years of experience, Pediatr Infect Dis J, vol.13, pp.113-116, 1994.

L. B. and G. Et, BCG ulcers and their effect on mother's willingness to allow their children to receive other antigens, Trans R Soc Trop Med Hyg, vol.84, p.430, 1990.

L. A. , W. , P. N. , D. N. , V. M. et al., Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics Adv Tub Res A bibliography of the complications of BCG vaccination. A comprehensive list of the world literature since the introduction of BCG up to, pp.107-193, 1982.

M. Jb and G. Jj, Quality control of BCG vaccine by WHO : a review of factors that influence vaccine effectiveness and safety, Bull World Health Organ, vol.68, pp.93-108, 1990.

N. Pk, S. Mf, P. P. , P. D. , J. B. et al., Outbreak of Bacillus Calmette-Guérin associated lymphadenitis and abscesses in Jamaican children, Pediatr Infect Dis, vol.9, pp.890-893, 1990.

O. Kl, R. Aj, L. Ma, D. J. , and J. Dj, Bacillus Calmette- Guerin complications in children born to HIV-1-infected women with a review of the litterature, Pediatrics, vol.95, pp.414-418, 1995.

O. , V. Bcgpdf, P. C. , C. Jl-romanus-v, F. A. et al., Nouveaux déficits immunitaires héréditaires et prédisposition génétique aux maladies infectieuses de l'enfant Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331 : implications for the vaccination policy in Sweden, Techniques vaccinales et effets indésirables de la vaccination 159 ANALYSE, pp.27-38, 1993.

S. D. , L. B. , J. T. Sicard-d, B. P. , D. B. et al., Disseminated bacille Calmette-Guerin infection : three recent Canadian cases. IMPACT. Immunization Monitoring Program, Active. Can Commun Dis Rep, Presse Med, vol.24, issue.21, pp.69-75, 1992.

T. E. , P. Md, S. Sfm, and F. R. , Disseminated Bacille Calmette- Guérin disease after vaccination : case report and review, Clin Infect Dis, vol.24, pp.1139-1146, 1997.

T. M. , T. , C. Jp, D. Y. , and L. P. , Tuberculous meningitis due to BCG in two previously healthy children, Lancet, vol.1, pp.440-441, 1988.

T. Sss and S. D. , Cases of BCG associated suppurative lymphadenitis, 2004.

?. Tuberculose, B. L. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, W. Feino-cunha-j, C. B. Olsen-a, and H. P. , Failure of the Mycobacterium bovis BCG vaccine : some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis, Infect Immun, vol.70, pp.672-678, 2002.

C. Jl and A. L. , Genetic dissection of immunity to mycobacteria : the human model, Annu Rev Immunol, vol.20, pp.581-620, 2002.

C. S. , M. V. , T. , S. S. , S. N. et al., Antimicrobial activity of MHC class I-restricted CD8 + T cells in human tuberculosis Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands, Proc Natl Acad Sci Science, vol.97, issue.264, pp.12210-12215, 1994.

D. J. , B. K. , and U. Jb, Technical and regulatory hurdles for DNA vaccines, Int J Parasitol, vol.33, pp.457-467, 2003.

D. , R. V. , D. O. , T. A. , D. Smet-n et al., Improved tuberculosis DNA vaccines by formulation in cationic lipids Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection, Infect Immun Proc Natl Acad Sci, vol.70, issue.89, pp.3681-3638, 1992.

G. M. , S. S. , M. Z. , W. F. , M. S. et al., Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with mycobacterium tuberculosis Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara, J Exp Med J Immunol, vol.199, issue.171, pp.649-659, 2003.

H. J. Miko-d, C. A. , L. V. , R. Dg, and K. Sh, Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes, Proc Natl Acad Sci, vol.95, pp.5299-5304, 1998.

H. Mk, B. S. , R. R. , C. J. , J. Wr-jr et al., Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis, Infect Immun, vol.68, pp.2888-2898, 2000.

H. Ma, H. G. , D. Bj, and M. , Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model, Proc Natl Acad Sci, vol.97, pp.13853-13858, 2000.

H. , H. Sm, C. B. , C. M. , and D. Az, The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue, Proc Natl Acad Sci, vol.100, pp.12420-12425, 2003.

H. K. , C. J. , D. O. , M. Dl, and Y. Am, Immunogenicity and protective efficacy of a tuberculosis DNA vaccine, Nat Med, vol.2, pp.893-898, 1996.

J. M. , P. Sw, L. M. , E. D. , and C. P. , Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine, Infect Immun, vol.67, pp.2867-2873, 1999.

L. Db, T. Re, B. Vl, L. Vm, and F. Lh, Therapy of tuberculosis in mice by DNA vaccination, Nature, vol.400, pp.269-271, 1999.

O. Im and C. Fm, Adoptive protection of the Mycobacterium tuberculosisinfected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin, Cell Immunol, vol.84, pp.113-120, 1984.

P. As, B. R. Brodin-p, H. M. , and C. St, Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti, Mol Microbiol, vol.46, pp.709-717, 2002.

P. As, M. L. Brodin-p, and B. R. Demangel, Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis, Nat Med, vol.9, pp.533-539, 2003.

S. H. , M. A. , and D. As, Use of T cell epitopes for vaccine development, Curr Drug Targets Infect Disord, vol.1, pp.303-313, 2001.

S. Ya, O. Pj, J. S. , A. Mr, and D. Dc, T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection, J Immunol, vol.165, pp.7140-7149, 2000.

T. A. , D. O. , L. B. , M. V. Van, and H. K. Berg-t, Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment, Infect Immun, vol.68, pp.3854-3860, 2000.

T. Jl, T. Oc, . Basaraba-rj, H. K. Belisle-jt, and O. Im, Pulmonary necrosis resulting from DNA vaccination against tuberculosis, Infect Immun, vol.71, pp.2192-2198, 2003.

Y. Ra, G. Bloom-br, I. J. Cm, T. D. , and D. Rw, Dissection of Mycobacterium tuberculosis antigens using recombinant DNA, Proc Natl Acad Sci, vol.82, pp.2583-2587, 1985.

?. Tuberculose, C. D. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, and F. V. , Improving the coverage of neonatal BCG vaccination, J Public Health Med, vol.18, pp.308-312, 1996.

E. Km and W. J. , A study of neonatal BCG immunisation within an acute hospital trust, J Public Health Med, vol.23, pp.335-338, 2001.

E. The, . Coordinators, . Tuberculosis, . In, . Who et al., Surveillance of tuberculosis in Europe, Report on tuberculosis cases notified, 2001.

H. Al, T. , T. E. , T. An, and F. Von, A cost-effectiveness analysis of universal versus selective immunisation with Mycobacterium bovis bacille Calmette-Guerin in Finland, Int J Tuberc Lung Dis, vol.7, pp.22-29, 2003.

?. Tuberculose, K. P. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie-186, M. D. , and C. L. , Neonatal BCG vaccination in Ireland : evidence of its efficacy in the prevention of childhood tuberculosis, Eur Respir J, vol.10, pp.619-623, 1997.

L. A. , W. , P. N. , D. N. , V. M. et al., Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics, Adv Tuberc Res, vol.21, pp.107-193, 1984.

R. V. , S. A. , and H. Ho, The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989, Tuber Lung Dis, vol.73, pp.150-161, 1992.

S. I. and S. Vh, The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates, J Epidemiol Community Health, vol.43, pp.15-24, 1989.

T. L. , D. D. , Z. J. , C. L. , and M. Gb, Survey of BCG vaccination policy in Europe : 1994-96, Bull World Health Organ, vol.76, pp.85-91, 1998.

V. L. Bcg-vaccination, In : Guidelines for tuberculosis control in New Zealand, 2003.

?. Tuberculose, A. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, A. Fa, A. Ms, B. Io et al., Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction ?, Am J Respir Crit Care Med, vol.152, pp.1575-1578, 1995.

T. Blower-sm, P. Mclean-ar, . Tc, H. Small-pm, and . Pc, Diagnostic standards and classification of tuberculosis in adults and children The intrinsic transmission dynamics of tuberculosis epidemics, Am J Respir Crit Care Med Nat Med, vol.161, issue.1, pp.1376-1395, 1995.

F. J. Ghebremichael-s, K. T. , H. S. , R. V. , and P. B. , Management of adverse reactions to Bacille Calmette-Guerin vaccine Resistant tuberculosis is spreading in Sweden. Molecular epidemiological strain identification by « fingerprinting » can make the infection tracing easier, Clin Infect Dis Lakartidningen, vol.31, issue.99, pp.75-76, 2000.

G. Eh and F. Kl, A dynamic model of tuberculosis epidemiology for Singapore, Ann Acad Med Singapore, vol.10, pp.40-49, 1981.

G. Pd, L. Kg, and S. Cb, Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination, Am Rev Respir Dis, vol.143, pp.490-495, 1991.

H. Sa, Method of measuring the « risk of infection » and its use as an indicator among BCG-vaccinated populations, Bull Int Union Tuberc, vol.59, pp.126-130, 1984.

H. Al, T. , T. E. , T. An, and F. Von, A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guerin in Finland, Int J Tuberc Lung Dis, vol.7, pp.22-29, 2003.

L. Mn, M. , R. Se, L. A. , W. et al., Missed opportunities for preventing tuberculosis among children younger than five years of age Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics, Pediatrics Adv Tuberc Res, vol.106, issue.21, pp.107-193, 1984.

M. R. , V. B. , R. I. , and S. Germain-y, The booster effect in two-step tuberculin testing among young adults in Montreal, Ann Intern Med, vol.120, pp.190-198, 1994.

M. Jb and G. Jj, Quality control of BCG vaccine by WHO : a review of factors that may influence vaccine effectiveness and safety, Bull World Health Organ, vol.68, pp.93-108, 1990.

R. Hl, Bases épidémiologiques de la lutte antituberculeuse. Union internationale contre la tuberculose et les maladies respiratoires, 1999.

R. V. , F. A. , T. P. , and W. Be, Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331 : implications for the vaccination policy in Sweden, Acta Paediatr, vol.82, pp.1043-1052, 1993.

S. Ee and S. Sr, Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function, Am J Epidemiol, vol.147, pp.398-406, 1998.

S. Kc and S. Jr, Bacille Calmette-Guerin vaccine, 1999.

S. I. and S. Vh, The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates, J Epidemiol Community Health, vol.43, pp.15-24, 1989.

T. Mm, T. Je, and T. Eo, Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence, Am J Respir Crit Care Med, vol.157, pp.1324-1327, 1998.

?. Tuberculose, C. Place-de-la-vaccination-dans-la-maîtrise-de-la-maladie, J. E. Jl, L. S. , B. S. et al., Immunological conditions of children with BCG disseminated infection, Lancet, vol.346, p.581, 1995.

C. Jl and A. L. , Genetic dissection of immunity to mycobacteria : the human model, Annu Rev Immunol, vol.20, pp.581-620, 2002.

D. Saint, B. G. Le-déficit-immunitaire-combiné-sévère-;-t-?-b-+-de-transmission-liée-au-chromosome, X. , E. Orphanet, D. Maipdf et al., http ://www.orpha.net/ data/patho/FR/fr-xdics Le déficit immunitaire combiné sévère de type alymphocytose, Acta Paediatr, vol.87, pp.702-704, 1998.